Comprehensive Analysis of Allulose Production: A Review and Update

If you buy allulose or formulate with it, production science matters as much as price. A recent review in Foods (DOI: 10.3390/foods13162572) shows why. D-allulose production has shifted decisively toward enzymes. The paper walks through the latest advances and points to a practical future for ingredient sourcing.

Why this paper matters

The review centers on enzymatic conversion. It covers immobilization, new enzyme discovery, directed evolution, and metabolic pathway modification. Each one solves a different production problem. Immobilization lets manufacturers reuse enzymes. Directed evolution tailors enzymes to industrial conditions. Pathway engineering moves allulose synthesis into whole cells. For formulators, these developments mean lower costs and more flexible supply options.

Regulation opened the door

In 2019, FDA granted GRAS status to D-allulose. China’s National Health Commission also approved allulose as a new food ingredient. That approval process helped open broader food categories. Ingredient buyers now face fewer regulatory hurdles when marketing products with allulose. The review treats regulatory acceptance as a key driver of the current production boom. That is correct. Approval without production capacity would not matter.

What the study did

The researchers reviewed recent progress in D-allulose production and updated the landscape. Their focus was clearly on biocatalysis. The evidence includes a multienzyme cascade developed for fruit juice. This cascade converts D-fructose to D-allulose directly in the juice. The reported conversion rate reaches 75%. Total yield sits at 60%. Those numbers are strong enough to interest any manufacturer evaluating in-situ allulose production.

Key findings at a glance

Area	What the review says	Why it matters
Immobilization technology	Covered as a major advancement	Points to more practical enzyme processes
Novel enzyme discovery	Covered as a route to better biocatalysts	Expands the toolbox for formulators
Directed evolution	Covered as an enzyme improvement strategy	Helps match enzymes to production conditions
Metabolic pathway modification	Covered as a biosynthetic approach	Opens the door to whole-cell production
Multienzyme cascade in juice	Converts D-fructose to D-allulose in juice	75% conversion, 60% total yield

What it means for manufacturers

The pattern is practical. Enzyme technology is clearly the focus. Immobilization, enzyme discovery, directed evolution, and pathway modification are all advancing at once. That matters for sourcing decisions.

The juice cascade changes the conversation. Instead of adding allulose as a dry ingredient, a manufacturer could potentially produce it within the product. That has sourcing and labeling implications. If you formulate beverages, watch this space.

For buyers, the regulatory picture is clearer than before. FDA GRAS and China NHC approval mean allulose can be used in more applications. Supply still depends on enzyme producers, but the science is moving in your favor. That is worth asking suppliers about.

FAQ

Does this review cover non-enzymatic production?

The update emphasizes enzymatic conversion methods and metabolic engineering. That fits the trend in the industry. Enzymatic routes have pulled ahead because they offer better specificity and cleaner processing.

What were the regulatory milestones?

FDA granted GRAS status to D-allulose in 2019. China’s NHC approved allulose as a new food ingredient, which enabled broader applications.

What results did the juice cascade achieve?

The multienzyme cascade converted D-fructose to D-allulose at a 75% conversion rate. The total yield was 60%.

What to watch next

The allulose production field is moving fast. The review’s emphasis on enzymes makes one thing clear: process innovation is happening at the enzyme level. For formulators, that opens choices. For buyers, it shifts the question from “does allulose work?” to “which production route fits my product?” The science is not standing still. Neither should your sourcing strategy.